Raymond Osarogiagbon, MBBS, FACP discusses the geographical disparities of #lungcancer in the US for LUNGevity Foundation's #healthequity Council #LCSM Jeanne Regnante

Honored to be presenting at this weekend's ASCO Quality Care Symposium in Boston. Not too late to register at quality.asco.org! Ready for #ASCOQLTY21!

Raymond Osarogiagbon, MBBS, FACP takes the stage! ASCO

#ASCOQLTY21 Great networking breakfast with the inspiring Raymond Osarogiagbon, MBBS, FACP talking about the importance of following your passion, and how to be a vector for change. ASCO #LatinasInMedicine #lcsm

Thanks to Raymond Osarogiagbon, MBBS, FACP for spending the hour at #ASCOQLTY21 to remind us to be fearless, courageous and free 💪🏼 great to meet other experts Dr. Estela Rodriguez and amazing #Hemonc fellows Ivy Riano, M.D. Pamela Contreras Chavez - hope to work together in the future 💪🏼

Geographic disparities at the state-level are leading to increased rates of death from lung cancer, according to Raymond Osarogiagbon, MBBS, FACP. #lcsm curetoday.com/view/some-area…

Watch Raymond Osarogiagbon, MBBS, FACP's #WCLC21 presentation: "Disparities in Lung Cancer Across the Population" here> ow.ly/iMQS50Gq2H1 #LCSM

As an #NOMPartner, I'm proud to support LUNGevity Foundation in recognizing KNOWvember as part of #LungCancerAwarenessMonth. It's vital that all non-small cell #lungcancer patients receive comprehensive biomarker testing to inform treatment. *Insert Link* #KnowYourBiomarker #NoOneMissed

As an #NOMPartner, I believe it's essential for non-small cell #lungcancer patients to receive biomarker testing to inform treatment. This KNOWvember, spread the word on the importance of #NSCLC patients receiving testing using #KnowYourBiomarker. #NoOneMissed #LCAM

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations. #lcsm #lungcancer Raymond Osarogiagbon, MBBS, FACP Vanderbilt School of Medicine curetoday.com/view/facing-di…

Be sure to check out Baptist Cancer Center's LCAM event at Crosstown Concourse tomorrow! Our organization is committed to raising awareness of lung cancer and reducing lung cancer rates not only in the Mid-South but nationally. RSVP at the link below: baptistcancer.center/lung-cancer-aw…

What can be done to optimize #lungcancer screening programs? Revisit research findings from #WCLC21:bit.ly/3JeuF6B Mary Pasquinelli Raymond Osarogiagbon, MBBS, FACP #LCSM

Examining Geographic, Socioeconomic, and Racial Disparities in Lung Cancer Prevention and Care Raymond Osarogiagbon, MBBS, FACP Baptist Health #lcsm #oncology ow.ly/N5Nz50I2KPN

Join the panel discussion on #TTLC22's Session on Therapy for Early Stage with donington @AngelQinMD U-M Rogel Cancer Center, Vincent Lam of Johns Hopkins Kimmel Cancer Center, Edgardo S. Santos, M.D., FACP, FASCO of Florida Precision Oncology R&C, Raymond Osarogiagbon, MBBS, FACP of Wake Forest Baptist - Comprehensive Cancer Center, Dr. Sanja Dacic of UPMC and nasser altorki of Weill Cornell Medicine

Study led by Raymond Osarogiagbon, MBBS, FACP at Baptist Health Cancer Center highlights the need for incidental detection of lung nodules. USPSTF #LDCT guidelines are a great start but only a start. #lungcancer Qure.ai ascopubs.org/doi/10.1200/JC…

#PLCClive22 Dr. Raymond Osarogiagbon, MBBS, FACP shows the significant state variation in low-dose CT screening for lung cancer. The rates are the lowest in areas where the need is the greatest (outlier is Kentucky where rates are very high). #HealthCareDisparities #LCSM

Being in the center of the lung cancer mortality belt of America, we are striving to narrow this gap by 25% in the next 10 years & eliminate the stigma of lung cancer in the Mid-South. Find out more about the Mid-South Miracle on the Right Care podcast. player.captivate.fm/episode/6cf246…

Now enrolling: SWOG Cancer Research Network S1934 #NASSIST trial: Neoadjuvant chemoradiation +/- #immunotherapy before surgery for superior sulcus non-small cell lung cancer. SWOG.org/clinical-trial…. PI: Raymond Osarogiagbon, MBBS, FACP #lungcancer #LCSM #NSCLC

What refinements should be made to the next edition of the TNM #lungcancer staging system? A session at #ELCC22 tackled this topic. Read a recap in ILCN: bit.ly/38nbpal Raymond Osarogiagbon, MBBS, FACP Ramon Rami Porta ESMO - Eur. Oncology #LCSM

•Thrilled to be speaking at Mass General Cancer Center’s 2023 #CancerEquityColloquium in April! All are welcome to join this hybrid event in Boston as we tackle the diverse issues that underlie #cancerinequities. Learn more & save your seat: bit.ly/3iWzTN6 Mass General Brigham Professional Development